{"nct_id":"NCT03282240","title":"Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US","status":"COMPLETED","status_verified_date":"2022-03","start_date":"2017-09-08","start_date_type":"ACTUAL","primary_completion_date":"2017-11-02","primary_completion_date_type":"ACTUAL","completion_date":"2018-04-19","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}